KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2025)

Elanco Animal Health's Total Current Liabilities history spans 9 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 21.44% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 21.44%, while the annual FY2025 figure was $1.6 billion, 21.44% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.6 billion at Elanco Animal Health, up from $1.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.0 billion in Q1 2021 and bottomed at $1.2 billion in Q1 2024.
  • The 5-year median for Total Current Liabilities is $1.4 billion (2021), against an average of $1.4 billion.
  • The largest annual shift saw Total Current Liabilities skyrocketed 187.49% in 2021 before it crashed 35.74% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $1.6 billion in 2021, then rose by 3.34% to $1.7 billion in 2022, then decreased by 27.09% to $1.2 billion in 2023, then increased by 5.96% to $1.3 billion in 2024, then increased by 21.44% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Total Current Liabilities are $1.6 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.4 billion (Q2 2025).